A POPULATION-BASED SYSTEMATIC SCREENING OF AAA. IMPLICATIONS IN THE COUNTRY WITH EUROPE S LOWEST TREATMENT INCIDENCE

Similar documents
President Dr. José Fernando Teixeira Vice - President Prof. Doutor Sérgio Sampaio

President Dr. José Fernando Teixeira Vice - President Prof. Doutor Sérgio Sampaio

Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

TITLE SECOND LINE SPEAKER

SYMPOSIUM PORTO OF APRIL INTERNATIONAL PALÁCIO HOTEL. Live Cases. New challenges, New solutions. Endorsed by.

Wales Abdominal Aortic Aneurysm Screening Programme (WAAASP) Policies

Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm

Disclosure. I do not have any potential conflict of interest

UPDATE REPORT: POPULATION SCREENING PROGRAMMES IN POWYS. This is a briefing report on the delivery of population screening in Powys

Preliminary data from the Liège Screening Programme Suggests the Reported Decline in AAA Prevalence is not Global

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Population screening and intervention for vascular disease in Danish men (VIVA): a randomized controlled trial

Management of a complex renal artery aneurysm

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Abdominal aortic aneurysm screening what is the need?

DENOMINATOR: Patients aged 18 and older with infrarenal non-ruptured endovascular AAA repairs

The Supera stent In retrograde vascular access for SFA ostium treatment: The SUPRA-FAST Registry

Role of Gender in TEVAR and EVAR results from the GREAT registry

Standardization of the CHEVAR procedure: How a standard approach has improved outcomes. Prof Peter Holt St George s, London

CIMAGO Scientific Meeting

Anatomical applicability of current off-the-shelf branched endografts in thoracoabdominal aortic aneurysms managed by open surgery.

Quality Indicators in Chronic Pain Management

Shared Decision Making screening for abdominal aortic aneurysm. Deciding whether to get screened for an abdominal aortic aneurysm (AAA)

Deciding whether to get screened for an abdominal aortic aneurysm (AAA)

Long-term Outcomes of the Western Australian Trial of Screening for Abdominal Aortic Aneurysms Secondary Analysis of a Randomized Clinical Trial

Porto Vascular Conference 2015 Programme

The OECD Health Care Quality Indicators Project

Characteristics and outcomes in men screened vs not screened for AAA in Sweden

ROLE OF VASCULAR SURGERY, CARDIAC SURGERY AND RADIOLOGY IN THE TREATMENT OF THORACIC AORTIC ANEURYSMS

How effective is preservation when viewed through a clinical and economic lens?

Takayasu disease Is it still a room for intervention? NO YES. BUT

Abdominal Aortic Aneurysm (AAA) Screening

CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES

Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany

Variation of stent placement for distal abdominal aorta Lesion

Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-mediated vs Surgical Cutdown for Closure of Large-bore Arterial Access

Cardiovascular risk in patients screened for AAA

Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results

EVAS is Associated with Lower All-Cause Mortality

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

Evolution of gender-related differences in outcome of EVAR

Treating very short necks ( 4mm <10mm) using the Endurant stent graft + EndoAnchors: 1-year results and current insights

The Subclavian Artery Access for difficult vascular interventions OGZ

A new classification of the diabetic ischaemic foot promotes a modern approach to treatment. Michael Edmonds King s College Hospital London

Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report

NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT.

Innovation forum EVAR

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Supplementary Online Content

Why and how to prep the vessel

The accident injuries situation

HYPOGASTRIC ARTERY PRESERVATION DURING EVAR: SURGICAL AND ENDOVASCULAR TECHNIQUES Single Centre Experience. Ilaria Ficarelli

Endovascular Treatment of Type II Endoleak Following TEVAR for Thoracic Aortic Aneurysm: Squeeze Technique to Reach the Aneurysmal Sac

Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the

How to select ruptured AAA for EVAR or open repair?

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

Discrepancy between the nonautomatic

Anatomical challenges in EVAR

Project Meeting Prague

Drug-Impaired Driving in Europe

Table 15.1 Summary information for kidney cancer in Ireland, Ireland RoI NI female male female male female male % of all new cancer cases

EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED.


Primary Palliative Care Task Force. Update 3,Montreal, Oct Taskforce Members. Scott Murray, Scotland Eric van Rijswijk, Holland

GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands

EDUCATIONAL COURSE PAEDIATRIC MUSCULOSKELETAL BASIC ULTRASOUND COURSE. Lisbon, September 2-4, 2018 PORTUGAL. This course is scientifically endorsed by

Approved. PASS INFORMATION Title

Your screening result: you have a small abdominal aortic aneurysm (AAA)

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Joint Programming in Neurodegenerative Disease Research (JPND)

Early outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD

ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients

Jes S. Lindholt. The role of fish oil in the natural history of abdominal aortic aneurysms. J Am Heart Assoc Jan 26;7(3).

Appendix 1: Medline Search Strategy

Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages?

Bifurcation stenting with BVS

Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization

From interventional cardiology to cardio-neurology. A new subspeciality

Chimney endovascular aneurysm sealing (ch-evas) for ruptured abdominal aortic aneurysms (AAA) due to type Ia endoleak following failed EVAS

HPV, Cancer and the Vaccination Programme

The Fate of Unexpected Events Occurring in Standard EVAR

Northern Ireland Abdominal Aortic Aneurysm (AAA) Screening Programme

Influence of patient selection and IFU compliance on outcomes following EVAS

WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK

A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Palliative nursing care of children and young people across Europe

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

Life after EVAR 1? The value of open repair for some patients reappears. D. Böckler University Hospital Heidelberg, Germany

Abdominal Aortic Aneurysm (AAA)

Canada s Malaria Recommendations CATMAT

Institutional Impact of EVAR s Incorporation in the Treatment of Abdominal Aortic Aneurysm: a 12 Years Experience Analysis

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Reducing the risk of CVD

Transcription:

A POPULATION-BASED SYSTEMATIC SCREENING OF AAA. IMPLICATIONS IN THE COUNTRY WITH EUROPE S LOWEST TREATMENT INCIDENCE Ricardo Castro-Ferreira, Pedro Mendes, Pedro Couto, Rosa Barreira, Fabiana Peixoto, Margarida Aguiar, Marina Neto, Dalila Rolim, José Pinto, Alberto Freitas, Paulo Gonçalves Dias, Sérgio Moreira Sampaio, Adelino Leite-Moreira, Armando Mansilha, José Fernando Teixeira

Disclosure Speaker name: Ricardo Castro Ferreira I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) X I do not have any potential conflict of interest

Background Western countries are describing similar AAA prevalence: 1.18% in UK, 1,7% in Sweden ( ) The incidence of AAA treated in each country is significantly more variable No data regarding the treatment of AAA in Portugal

Background In Medline, the algorithm: ["vascunet" OR "national registry" OR "Hospital discharge records database" OR "National inpatient sample" OR "Patient Register"] AND "abdominal aortic aneurysm". UK -> 11.6 / 100 000 Italy -> 18 / 100 000 Spain -> 6.7 / 100 000 Norway -> 18.3 / 100 000 Sweden -> 12.7 / 100 000 Denmark -> 16.4 / 100 000 USA -> 14.1 / 100 000

Background In Portugal the number of AAA treated was assessed by evaluation of the central healthcare administrative database: In 2010 361 AAA were treated in Portugal Portuguese population in 2010-10.570.000 inhabitants 3,42 / 100 000

Background AAA treated by 100 000 20 18 16 14 12 11.6 18 18.3 12.7 16.4 14.1 10 8 6 4 2 6.7 3.4 0 UK Italy Spain Norway Sweden Denmark USA Portugal

Background The population adjusted incidence of AAA treatment in Portugal is up to 5 times lower than other western countries Assuming similar treatment criteria, these can only be justified by: Low prevalence Underdiagnosis

Background The population adjusted incidence of AAA treatment in Portugal is up to 5 times lower than other western countries It is imperative to know the real AAA prevalence in Portugal Assuming similar treatment criteria, these can only be justified by: An experimental Low prevalence population screening will partially address that question Underdiagnosis

Objective To perform an experimental population screening in men with age 65 years

Methods Identify the population to assess Porto metropolitan area primary health care centre: Total population: 15.230 Men 65 years: 963 Exclusion criteria - Severe dementia or disability Eligible population 933 patients

Methods Patients were contacted by phone and registered letter Aortic ultrasound was preformed by experienced professionals Aortic diameter was measured by the leading-edge-to-leading-edge method AAA 4,5cm -> patient is referred to our vascular center AAA 3 to 4,5cm -> anual aortic doppler in primary health care

Results Of the 933 eligeble, 715 patients participated in the study Participation rate of 76,6% AAA prevalence of 2,2%

Results HAD PREVIOUSLY HEARD ABOUT THE DISEASE? Yes No 85% had never heard about AAA

1, Benson, Ruth A., Rebecca Poole, Shelagh Murray, Paul Moxey, and Ian M. Loftus. "Screening Results from a Large United Kingdom Abdominal Aortic Aneurysm Screening Center in the Context of Optimizing United Kingdom National Abdominal Aortic Aneurysm Screening Programme Protocols." Journal of Vascular Surgery 63.2 (2016): 301-04. Web. 2. Svensjö, S. "Abdominal Aortic Aneurysm Screening in Sweden." Gefässchirurgie 19.6 (2014): 540-44. Web. Discussion AAA prevalence UK 1 Sweden 2 1,18% 1,7% Portugal 2,1% Treatment incidence UK Sweden 11.6 12.7 Portugal 3.41

1, Benson, Ruth A., Rebecca Poole, Shelagh Murray, Paul Moxey, and Ian M. Loftus. "Screening Results from a Large United Kingdom Abdominal Aortic Aneurysm Screening Center in the Context of Optimizing United Kingdom National Abdominal Aortic Aneurysm Screening Programme Protocols." Journal of Vascular Surgery 63.2 (2016): 301-04. Web. 2. Svensjö, S. "Abdominal Aortic Aneurysm Screening in Sweden." Gefässchirurgie 19.6 (2014): 540-44. Web. Discussion AAA prevalence UK Sweden 1,18% 1,7% Portugal 2,1% Incidence of treatment UK Sweden 11.6 12.7 Portugal 3.41

1, Benson, Ruth A., Rebecca Poole, Shelagh Murray, Paul Moxey, and Ian M. Loftus. "Screening Results from a Large United Kingdom Abdominal Aortic Aneurysm Screening Center in the Context of Optimizing United Kingdom National Abdominal Aortic Aneurysm Screening Programme Protocols." Journal of Vascular Surgery 63.2 (2016): 301-04. Web. 2. Svensjö, S. "Abdominal Aortic Aneurysm Screening in Sweden." Gefässchirurgie 19.6 (2014): 540-44. Web. Discussion AAA prevalence UK Sweden 2 1,18% 1,7% Portugal 2,1% Incidence of treatment UK Sweden 11.6 12.7 Portugal 3.41

Conclusion AAA prevalence in Portugal is similar to the internationally described...but the population adjusted incidence of AAA treatment in Portugal is dramatically inferior An important number of potentially fatal AAA remain to be diagnosed in Portugal

Conclusion What's next Based on these numbers, a multidisciplinary workgroup was created to develop a systematic national screening protocol

Thank you!

A POPULATION-BASED SYSTEMATIC SCREENING OF AAA. IMPLICATIONS IN THE COUNTRY WITH EUROPE S LOWEST TREATMENT INCIDENCE Ricardo Castro-Ferreira, Pedro Mendes, Pedro Couto, Rosa Barreira, Fabiana Peixoto, Margarida Aguiar, Marina Neto, Dalila Rolim, José Pinto, Alberto Freitas, Paulo Gonçalves Dias, Sérgio Moreira Sampaio, Adelino Leite-Moreira, Armando Mansilha, José Fernando Teixeira